Key result
Inhibition of CaMKII attenuated the ATP-dependent rundown of TMEM16A-mediated calcium-activated chloride currents, whereas inhibition of PP1/PP2A promoted rundown, indicating regulation by phosphorylation.
Why the study?
This study explored the mechanism by which Ca2+-activated Cl- channels encoded by the Tmem16a gene are regulated by CaMKII and PP1 and PP2A.
Absolute Event Rate: 62.5% vs 32.7%
p-value: p=<0.001
TMEM16A-mediated Ca2+-activated Cl- channels are regulated by CaMKII and PP1/PP2A, with serine 528 playing a key role in CaMKII regulation.
No immediate clinical implications; leaves open CaMKII/PP1/PP2A roles in native TMEM16A channels.
This study explored the mechanism by which Ca2+-activated Cl− channels (CaCCs) encoded by the Tmem16a gene are regulated by calmodulin-dependent protein kinase II (CaMKII) and protein phosphatases 1 (PP1) and 2A (PP2A). Ca2+-activated Cl− currents ( IClCa) were recorded from HEK-293 cells expressing mouse TMEM16A. IClCa were evoked using a pipette solution in which free Ca2+ concentration was clamped to 500 nM, in the presence (5 mM) or absence of ATP. With 5 mM ATP, IClCa decayed to <50% of the initial current magnitude within 10 min after seal rupture. IClCa rundown seen with ATP-containing pipette solution was greatly diminished by omitting ATP. IClCa recorded after 20 min of cell dialysis with 0 ATP were more than twofold larger than those recorded with 5 mM ATP. Intracellular application of autocamtide-2-related inhibitory peptide (5 µM) or KN-93 (10 µM), two specific CaMKII inhibitors, produced a similar attenuation of TMEM16A rundown. In contrast, internal application of okadaic acid (30 nM) or cantharidin (100 nM), two nonselective PP1 and PP2A blockers, promoted the rundown of TMEM16A in cells dialyzed with 0 ATP. Mutating serine 528 of TMEM16A to an alanine led to a similar inhibition of TMEM16A rundown to that exerted by either one of the two CaMKII inhibitors tested, which was not observed for three putative CaMKII consensus sites for phosphorylation (T273, T622, and S730). Our results suggest that TMEM16A-mediated CaCCs are regulated by CaMKII and PP1/PP2A. Our data also suggest that serine 528 of TMEM16A is an important contributor to the regulation of IClCa by CaMKII.
No takes yet. Share an insight, caveat, or question.
Ayon et al. (2019) studied this question. CaMKII inhibitors (ARIP, KN-93) and PP1/PP2A inhibitors (Okadaic acid, Cantharidin) vs. Control (vehicle or ATP variation) was evaluated on TMEM16A-mediated Ca2+-activated Cl- current (IClCa) rundown (p=<0.001). Inhibition of CaMKII attenuated the ATP-dependent rundown of TMEM16A-mediated calcium-activated chloride currents, whereas inhibition of PP1/PP2A promoted rundown, indicating regulation by phosphorylation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: